Spark Therapeutics competitive analysis

Explore Spark Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 16, 2026
Patent NumberPublication DateTitleTotal Oppositions
Dec 20, 2023Scalable High Recovery Methods For Producing High Yield Recombinant Adeno-Associated Viral (Raav) Vector And Recombinant Adeno-Associated Viral (Raav) Vectors Produced Thereby1
Oct 12, 2022Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing Immunoglobulins8

Latest PTAB cases involving Spark Therapeutics

Discover the latest PTAB cases involving Spark Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Spark Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 16, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SPARK THERAPEUTICS - 9 - -
BAYER3461 - -
BAYER INTELLECTUAL30 - - 4
GATESIP1 - - -